Published on: October 26, 2020 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Oral Semaglutide
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3opjNJz

0 Comments